EPE. G. Plotnikova

E. G. Plotnikova

*This is an algorithmically generated author record based on publicly available information.

E. G. Plotnikova has a total of 7 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Morbidity of the population in the Orenburg region with viral hepatitis for the period from 2016–2020.

    by S. V. Vyaltsin, K. A. Klyueva, E. G. Plotnikova, M. V. Mirzayeva, A. C. Vyaltsin, А. С. Вяльцин

    Introduction. Hepatitis B is one of the urgent problems of modern medicine and is included in the list of socially significant diseases [1, 3, 4]. According to WHO, about 4 million cases of acute hepatitis B are detected annually in the world, which can turn into a chronic form with the subsequent development of adverse outcomes, and also requires significant financial costs. In 2016, the 69th session of the World Health Assembly approved a strategy to combat viral hepatitis until 2030. In the Orenburg region, preventive measures carried out within the framework of the National Priority Project in the field of healthcare (section Vaccination prevention) for many years have significantly reduced the number of primary infections with viral hepatitis B.Target. To show the effectiveness of preventive immunization against hepatitis B and to assess the dependence of the incidence rate on the coverage of the population with hepatitis B vaccination on the example of the Orenburg region. Materials and methods. Data from the Federal statistical observation forms No. 2 “Information on infectious and parasitic diseases”, No. 6 “Information on the contingents of children and adults vaccinated against infectious diseases” in the Orenburg region for 2016–2020.Results. The coverage of vaccination against viral hepatitis B in the Orenburg region was analyzed, during the analyzed period, the coverage of vaccination increased significantly, as a result of which there is a tendency to decrease the incidence of acute viral hepatitis by 3,4 times.Conclusion. This article shows the effectiveness of preventive immunization against viral hepatitis B and evaluates the dependence of the incidence rate on the coverage of the population with vaccination against viral hepatitis B for the period from 2016 to 2020 on the example of the Orenburg region.


  • Epidemiology of the novel coronavirus infection in the Orenburg Region in the period from 2020 to 2022

    by S. V. Vyaltsin, E. G. Plotnikovа, T. N. Kalinina, N. R. Mikhaylova, M. V. Mirzaeva, A. V. Vyaltsin

    The article presents the results of a study of the dynamics and structure of the incidence of a new coronavirus infection (COVID-19) in the Orenburg region for 2020–2022, in view of the circulating genovariant of the SARS-CoV-2 virus. The data of operational monitoring of the Department of Rospotrebnadzor used in the Orenburg region. On the territory of the Orenburg region, the circulating genovariant of the coronavirus infection and its influence on the incidence rate, age, sex of patients and the clinical form of diseases, 3 periods allocated: The 1st period (March 2020 — March 2021) characterized by the circulation of the Wuhan SARS-CoV-2 genovariant; in the 2nd period (April — December 2021), the SARS-CoV-2 Delta genovariant and, along with it, the British SARS-CoV-2 Alpha genovariant became widespread; in 3In the 1st period (January-December 2022), the SARS-CoV-2 Omicron gene variant prevailed. The incidence rate in every subsequent period was significantly higher than in the previous one. In all periods, women have highest morbidity, the age group at risk was people over 65 years old. The clinical variants of the disease was heterogeneous: the dynamics showed an increase in the proportion of acute respiratory viral infections, a decrease in the proportion of pneumonia and asymptomatic forms. The most severe course of the disease and the highest mortality established in the second period, against the background of the intensive dissemination of the most virulent Delta genvariant. The circulation of the contagious Omicron genevariant can be explained the peak values of morbidity at the beginning of the third period. The territorial unevenness of the distribution of morbidity revealed. The correlation established between the circulating genovariants of the SARS-CoV-2 virus and the manifestations of the epidemic process of a new coronavirus infection (COVID-19) in the Orenburg Region in 2020–2022.